sulfametrole   Click here for help

GtoPdb Ligand ID: 12702

Approved drug
sulfametrole is an approved drug
Compound class: Synthetic organic
Comment: Sulfametrole is a sulfonamide antibacterial compound.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 139.82
Molecular weight 286.33
XLogP 0.06
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COC1=NSN=C1NS(=O)(=O)C2=CC=C(C=C2)N
Isomeric SMILES COC1=NSN=C1NS(=O)(=O)C2=CC=C(C=C2)N
InChI InChI=1S/C9H10N4O3S2/c1-16-9-8(11-17-12-9)13-18(14,15)7-4-2-6(10)3-5-7/h2-5H,10H2,1H3,(H,11,13)
InChI Key IZOYMGQQVNAMHS-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Oral or intravenous formulations of sulfametrole + trimethoprim are authorised in several European countries as an alternative to co-trimoxazole. There is no information regarding approval for clinical use of this drug on the US FDA website.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Sulfonamides are structural analogues of 4-aminobenzoic acid (pABA) an intermediate in the de novo synthesis of folate by some prokaryotes, lower eukaryotes and plants [2]. The antibacterial MMOA is competitive inhibition of bacterial dihydropteroate synthase (DHPS) resulting in a block of folate biosynthesis [1].